Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
How to Interpret Your Results Lab reports rarely tell you what your number actually means
Start your journey to better health today with IV and IM Vitamin Therapy
Once B12 levels improve and you are no longer deficient, your treatment may be switched to supplements
Individuals taking prescription medications, particularly those affecting blood sugar or blood pressure, should consult healthcare providers before combining treatments
Proper reconstitution technique is essential to maintain the peptides stability and prevent issues such as gelling or clumping, which can compromise the quality and reliability of research data